Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2002 Nov;61(Suppl 2):ii100–ii102. doi: 10.1136/ard.61.suppl_2.ii100

Role of interleukin 15 and interleukin 18 in inflammatory response

F Liew, I McInnes
PMCID: PMC1766710  PMID: 12379638

Full Text

The Full Text of this article is available as a PDF (74.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bathon J. M., Martin R. W., Fleischmann R. M., Tesser J. R., Schiff M. H., Keystone E. C., Genovese M. C., Wasko M. C., Moreland L. W., Weaver A. L. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000 Nov 30;343(22):1586–1593. doi: 10.1056/NEJM200011303432201. [DOI] [PubMed] [Google Scholar]
  2. Bondeson J., Foxwell B., Brennan F., Feldmann M. Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc Natl Acad Sci U S A. 1999 May 11;96(10):5668–5673. doi: 10.1073/pnas.96.10.5668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dinarello C. A. Interleukin-18. Methods. 1999 Sep;19(1):121–132. doi: 10.1006/meth.1999.0837. [DOI] [PubMed] [Google Scholar]
  4. Ghayur T., Banerjee S., Hugunin M., Butler D., Herzog L., Carter A., Quintal L., Sekut L., Talanian R., Paskind M. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature. 1997 Apr 10;386(6625):619–623. doi: 10.1038/386619a0. [DOI] [PubMed] [Google Scholar]
  5. Giri J. G., Kumaki S., Ahdieh M., Friend D. J., Loomis A., Shanebeck K., DuBose R., Cosman D., Park L. S., Anderson D. M. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J. 1995 Aug 1;14(15):3654–3663. doi: 10.1002/j.1460-2075.1995.tb00035.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grabstein K. H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M. A., Ahdieh M. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 1994 May 13;264(5161):965–968. doi: 10.1126/science.8178155. [DOI] [PubMed] [Google Scholar]
  7. Gracie J. A., Forsey R. J., Chan W. L., Gilmour A., Leung B. P., Greer M. R., Kennedy K., Carter R., Wei X. Q., Xu D. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest. 1999 Nov;104(10):1393–1401. doi: 10.1172/JCI7317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Joosten L. A., van De Loo F. A., Lubberts E., Helsen M. M., Netea M. G., van Der Meer J. W., Dinarello C. A., van Den Berg W. B. An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J Immunol. 2000 Dec 1;165(11):6553–6558. doi: 10.4049/jimmunol.165.11.6553. [DOI] [PubMed] [Google Scholar]
  9. Kanakaraj P., Ngo K., Wu Y., Angulo A., Ghazal P., Harris C. A., Siekierka J. J., Peterson P. A., Fung-Leung W. P. Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J Exp Med. 1999 Apr 5;189(7):1129–1138. doi: 10.1084/jem.189.7.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lipsky P. E., van der Heijde D. M., St Clair E. W., Furst D. E., Breedveld F. C., Kalden J. R., Smolen J. S., Weisman M., Emery P., Feldmann M. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000 Nov 30;343(22):1594–1602. doi: 10.1056/NEJM200011303432202. [DOI] [PubMed] [Google Scholar]
  11. Lodolce J. P., Boone D. L., Chai S., Swain R. E., Dassopoulos T., Trettin S., Ma A. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 1998 Nov;9(5):669–676. doi: 10.1016/s1074-7613(00)80664-0. [DOI] [PubMed] [Google Scholar]
  12. Marks-Konczalik J., Dubois S., Losi J. M., Sabzevari H., Yamada N., Feigenbaum L., Waldmann T. A., Tagaya Y. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11445–11450. doi: 10.1073/pnas.200363097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McInnes I. B., Gracie J. A., Leung B. P., Wei X. Q., Liew F. Y. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today. 2000 Jul;21(7):312–315. doi: 10.1016/s0167-5699(00)01648-0. [DOI] [PubMed] [Google Scholar]
  14. McInnes I. B., Leung B. P., Sturrock R. D., Field M., Liew F. Y. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med. 1997 Feb;3(2):189–195. doi: 10.1038/nm0297-189. [DOI] [PubMed] [Google Scholar]
  15. McInnes I. B., Liew F. Y. Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis. Immunol Today. 1998 Feb;19(2):75–79. doi: 10.1016/s0167-5699(97)01205-x. [DOI] [PubMed] [Google Scholar]
  16. McInnes I. B., al-Mughales J., Field M., Leung B. P., Huang F. P., Dixon R., Sturrock R. D., Wilkinson P. C., Liew F. Y. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med. 1996 Feb;2(2):175–182. doi: 10.1038/nm0296-175. [DOI] [PubMed] [Google Scholar]
  17. Niedbala Wanda, Wei Xiaoqing, Liew Foo Y. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro. Eur J Immunol. 2002 Feb;32(2):341–347. doi: 10.1002/1521-4141(200202)32:2<341::AID-IMMU341>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  18. Nishimura H., Yajima T., Naiki Y., Tsunobuchi H., Umemura M., Itano K., Matsuguchi T., Suzuki M., Ohashi P. S., Yoshikai Y. Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J Exp Med. 2000 Jan 3;191(1):157–170. doi: 10.1084/jem.191.1.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Oppenheimer-Marks N., Brezinschek R. I., Mohamadzadeh M., Vita R., Lipsky P. E. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J Clin Invest. 1998 Mar 15;101(6):1261–1272. doi: 10.1172/JCI1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rezzonico R., Chicheportiche R., Imbert V., Dayer J. M. Engagement of CD11b and CD11c beta2 integrin by antibodies or soluble CD23 induces IL-1beta production on primary human monocytes through mitogen-activated protein kinase-dependent pathways. Blood. 2000 Jun 15;95(12):3868–3877. [PubMed] [Google Scholar]
  21. Ribbens C., Dayer J. M., Chizzolini C. CD40-CD40 ligand (CD154) engagement is required but may not be sufficient for human T helper 1 cell induction of interleukin-2- or interleukin-15-driven, contact-dependent, interleukin-1beta production by monocytes. Immunology. 2000 Feb;99(2):279–286. doi: 10.1046/j.1365-2567.2000.00948.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ruchatz H., Leung B. P., Wei X. Q., McInnes I. B., Liew F. Y. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol. 1998 Jun 1;160(11):5654–5660. [PubMed] [Google Scholar]
  23. Shah M. H., Hackshaw K. V., Caligiuri M. A. A role for IL-15 in rheumatoid arthritis? Nat Med. 1998 Jun;4(6):643–643. doi: 10.1038/nm0698-643a. [DOI] [PubMed] [Google Scholar]
  24. Thurkow E. W., van der Heijden I. M., Breedveld F. C., Smeets T. J., Daha M. R., Kluin P. M., Meinders A. E., Tak P. P. Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J Pathol. 1997 Apr;181(4):444–450. doi: 10.1002/(SICI)1096-9896(199704)181:4<444::AID-PATH778>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  25. Vey E., Burger D., Dayer J. M. Expression and cleavage of tumor necrosis factor-alpha and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells. Eur J Immunol. 1996 Oct;26(10):2404–2409. doi: 10.1002/eji.1830261021. [DOI] [PubMed] [Google Scholar]
  26. Waldmann T. A., Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol. 1999;17:19–49. doi: 10.1146/annurev.immunol.17.1.19. [DOI] [PubMed] [Google Scholar]
  27. Wei X. Q., Leung B. P., Arthur H. M., McInnes I. B., Liew F. Y. Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J Immunol. 2001 Jan 1;166(1):517–521. doi: 10.4049/jimmunol.166.1.517. [DOI] [PubMed] [Google Scholar]
  28. Zhang X., Sun S., Hwang I., Tough D. F., Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity. 1998 May;8(5):591–599. doi: 10.1016/s1074-7613(00)80564-6. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES